We explore the issues faced by manufacturers and payers for oncology combination pricing and the pot...
Read moreWe explore the rapidly evolving market access landscape in respect to digital health applications in...
Read moreDigital health technology played a vital role during the COVID-19 pandemic as there was a rapid usag...
Read moreWe explore the coordinated HTA networks involved in EUnetHTA, define the HTACG and the deliverables ...
Read moreOncology products, advanced therapy medicinal products (ATMPs) and medical devices are entering the ...
Read moreWe explore joint scientific consultations; what they mean and why they are important to manufacturer...
Read moreWe explore what the joint clinical assessment (JCA) is, its process and what future developments may...
Read moreWe've prepared an analysis of the top 10 most expensive drugs in the US compared with Germany, in th...
Read moreUsing Early Access Programs (EAPs) to give patients with life threatening conditions access to medic...
Read moreAmong the most expensive therapies are gene therapies that show promise to transform inherited disor...
Read more